Prevalence and Assessment of Associated Risk Factors of Hepatitis B and C Infections in Low-Socioeconomic Communities

References

• Prevention and control of viral hepatitis infection: frame work for global action. 2012 (2020). www.who.int/hepatitis/publications/Framework/en/
   Google Scholar
• Lim JK , NguyenMH, KimWR, GishR, PerumalswamiP, JacobsonIM. Prevalence of chronic hepatitis B virus infection in the United States. Am. J. Gastroenterol., 115(9), 1429–1438 (2020).
   PubMed Web of Science ®Google Scholar
• Petruzziello A , MariglianoS, LoquercioG, CozzolinoA, CacciapuotiC. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J. Gastroenterol., 22(34), 7824 (2016).
   PubMed Web of Science ®Google Scholar
• Wiktor SZ , HutinYJ. The global burden of viral hepatitis: better estimates to guide hepatitis elimination efforts. Lancet, 388(10049), 1030 (2016).
   PubMed Web of Science ®Google Scholar
• World Health Organization . Combating hepatitis B and C to reach elimination by 2030: advocacy brief (2016). https://apps.who.int/iris/handle/10665/206453
   Google Scholar
• Attaullah S , KhanS, AliI. Hepatitis C virus genotypes in Pakistan: a systemic review. Virol. J., 8(1), 1–6 (2011).
   PubMedGoogle Scholar
• Chen CL , HuangJY, WangCHet al. Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7. 2. Nat. Commun., 8(1), 1–17 (2017).
   PubMedGoogle Scholar
• Geller R , EstadaÚ, PerisJBet al. Highly heterogeneous mutation rates in the hepatitis C virus genome. Nat. Microbiol., 1(7), 1–7 (2016).
   Web of Science ®Google Scholar
• Yokokawa H , HigashinoA, SuzukiSet al. Induction of humoural and cellular immunity by immunisation with HCV particle vaccine in a non-human primate model. Gut, 67(2), 372–379 (2018).
   PubMed Web of Science ®Google Scholar
• Selzer L , ZlotnickA. Assembly and release of hepatitis B virus. Cold Spring Harb. Perspect. Med., 5(12), a021394 (2015).
   PubMed Web of Science ®Google Scholar
• World Health Organization . Hepatitis B (2020). www.who.int/news-room/fact-sheets/detail/hepatitis-b
   Google Scholar
• Haqqi A , MunirR, KhalidMet al. Prevalence of hepatitis C virus genotypes in Pakistan: current scenario and review of literature. Viral Immunol., 32(9), 402–413 (2019).
   PubMed Web of Science ®Google Scholar
• Mehmood S , RazaH, AbidFet al. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. J. Public Health, 28(6), 751–764 (2020).
   Google Scholar
• Ringehan M , MckeatingJA, ProtzerU. Viral hepatitis and liver cancer. Philos. Trans. R. Soc. Lond., B, Biol. Sci., 372(1732), 20160274 (2017).
   PubMed Web of Science ®Google Scholar
• Kvitko DT , BastosGaN, PintoMEB. Prevalence of risk factors for hepatitis C and associated factors: a population-based study in southern Brazil. Arq. Gastroenterol., 50, 117–122 (2013).
   PubMedGoogle Scholar
• Omland LH , OslerM, JepsenPet al. Socioeconomic status in HCV infected patients–risk and prognosis. Clin. Epidemiol., 5, 163 (2013).
   PubMedGoogle Scholar
• Lim AG , WalkerJG, MafirakurevaNet al. Effects and cost of different strategies to eliminate hepatitis C virus transmission in Pakistan: a modelling analysis. Lancet Glob. Health, 8(3), e440–e450 (2020).
   PubMed Web of Science ®Google Scholar
• Mahmud S , AlKanaani Z, Abu-RaddadLJ. Characterization of the hepatitis C virus epidemic in Pakistan. BMC Infect. Dis., 19(1), 1–11 (2019).
   PubMed Web of Science ®Google Scholar
• Sample size calculator – confidence level, confidence interval, sample size, population size, relevant population – creative research systems (2018). www.surveysystem.com/sscalc.htm
   Google Scholar
• Islamabad population 2020 (demographics, maps, graphs) (2020). https://worldpopulationreview.com/world-cities/islamabad-population
   Google Scholar
• Gétaz L , CasillasA, SiegristCAet al. Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison. J. Glob. Health, 8(2), 020407 (2018).
   PubMed Web of Science ®Google Scholar
• Martini S . Hepatitis C and liver transplantation. Minerva Gastroenterol. Dietol., 64(2), 158–169 (2017).
   PubMedGoogle Scholar
• Ataei B , AlavianSM, Shahriari-FardFet al. A case-control study of risk factors for hepatitis B infection: a regional report among Isfahanian adults. J. Res. Med. Sci., 24, 22 (2019).
   PubMed Web of Science ®Google Scholar
• Keshavarz K , KebriaeezadehA, AlavianSMet al. Economic burden of hepatitis B virus-related diseases: evidence from Iran. Hepat. Mon., 15(4), e25854 (2015).
   PubMed Web of Science ®Google Scholar
• Edmunds BL , MillerER, TsourtosG. The distribution and socioeconomic burden of hepatitis C virus in South Australia: a cross-sectional study 2010–2016. BMC Public Health, 19(1), 1–16 (2019).
   PubMedGoogle Scholar
• Satti R , FarahM, KhanMIet al. Prevalence of hepatitis C virus in urban Ghettos of twin cities. Pak. J. Zool., 44(4), 937–943 (2012).
   Web of Science ®Google Scholar
• Khokhar N , GillML, MalikGJ. General seroprevalence of hepatitis C and hepatitis B virus infections in population. J. Coll. Physicians Surg. Pak., 14(9), 534–536 (2004).
   PubMedGoogle Scholar
• Samo AA , LaghariZA, BaigNM, KhosoGM. Prevalence and risk factors associated with hepatitis B and C in Nawabshah, Sindh, Pakistan. Am. J. Trop. Med., 104(3), tpmd201228 (2020).
   PubMed Web of Science ®Google Scholar
• Arshad A , ArshadM, PervaizR, FarzanaJ, AhmadN, AliIS. Prevalence of active hepatitis-C infection in the general population of district Mardan, Khyber Pakhtunkhwa. Pakistan Public Health Biol. Sci., 1(1), 3–8 (2012).
   Google Scholar
• Ul Huda W , JameelN, FasihU, RehmanA, ShaikhA. Prevalence of hepatitis B and C in urban patients undergoing cataract surgery. Pak. J. Ophthal., 29(3), 147–150 (2013).
   Google Scholar
• Akhtar N , IlyasM, MuhammadK, ShamsS, SaeedK, AsadullahA. Prevalence of Hepatitis C virus infections among the general population of Buner, Khyber Pakhtunkhwa, Pakistan. Biomed. Res. Ther., 3(12), 1003–1017 (2016).
   Google Scholar
• Yee LJ , WeissHL, LangnerRG, HerreraJ, KaslowRA, Van LeeuwenDJ. Risk factors for acquisition of hepatitis C virus infection: a case series and potential implications for disease surveillance. BMC Infect Dis., 1(1), 1–5 (2001).
   PubMedGoogle Scholar
• Akhtar AM , MajeedS, JamilM, RehmanA. Prevalence of hepatitis C infection. Professional Med. J., 22(11), 1390–1396 (2015).
   Google Scholar
• Qureshi H , BileK, JoomaR, AlamS, AfridH. Prevalence of hepatitis B and C viral infections in Pakistan: findings of a national survey appealing for effective prevention and control measures. East. Mediterr. Health J., 16, 15–23 (2010).
   PubMedGoogle Scholar
• Chakrabarty P , RudraS, HossainMA. Prevalence of HBV and HCV among the multi-transfused beta thalassemic major patients in a day care centre of blood transfusion department of Mymensingh Medical College Hospital. Mymensingh Med. J., 23(2), 235–241 (2014).
   PubMedGoogle Scholar
• Ejiofor O , IbeB, EmodiIet al. The role of blood transfusion on the prevalence of hepatitis C virus antibodies in children with sickle-cell anaemia in Enugu, South East Nigeria. Niger. J. Clin. Pract., 12(4), 235–241 (2009).
   Web of Science ®Google Scholar
• Adeyemi A , OmoladeO, Raheem-AdemolaR. Immunochromatographic testing method for hepatitis B, C in blood donors. J. Antivir. Antiretrovir. S, 3, (2013).
   Google Scholar
• Jafari S , BuxtonJA, AfsharK, CopesR, BaharlouS. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can. J. Public Health, 103(3), 207–212 (2012).
   PubMed Web of Science ®Google Scholar
• Tohme RA , HolmbergSD. Transmission of hepatitis C virus infection through tattooing and piercing: a critical review. Clin. Infect. Dis., 54(8), 1167–1178 (2012).
   PubMed Web of Science ®Google Scholar
• Carney K , DhallaS, AytamanA, TennerCT, FrancoisF. Association of tattooing and hepatitis C virus infection: A multicenter case-control study. Hepatology, 57(6), 2117–2123 (2013).
   PubMed Web of Science ®Google Scholar
• Ziaee M , EbrahimzadehA, AzarkarZet al. Seroprevalence and risk factors for hepatitis B in an adult population: the first report from Birjand, South Khorasan, Iran. Hepat. Mon., 16(9), e36452 (2016).
   PubMed Web of Science ®Google Scholar
• Gacche RN , Al-MohaniSK. Seroprevalence and risk factors for hepatitis C virus infection among general population in central region of Yemen. Hepat. Res. Treat., 2012, 689726 (2012).
   PubMedGoogle Scholar
• Al Humayed SM . The risk of acquiring hepatitis B and C viral infections following tooth extraction in Al Farsha area, south-western Saudi Arabia. Saudi J. Oral. Dent. Res., 7(2), 127–131 (2016).
   Google Scholar
• Schillie S , VellozziC, ReingoldAet al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. Morb. Mortal. Wkly. Rep., 67(1), 1 (2018).
   PubMedGoogle Scholar
• Pereira LM , MartelliCM, MoreiraRCet al. Prevalence and risk factors of hepatitis C virus infection in Brazil, 2005 through 2009: a cross-sectional study. BMC Infect. Dis., 13(1), 1–12 (2013).
   PubMedGoogle Scholar
• Pracoyo NE , SuratriMaL, RoselindaR, SetiawatyV. The association of hepatitis C serological status with several risk factors in Indonesia. Int. Sch. Res. Notices, 2016, 3018135 (2016).
   PubMedGoogle Scholar
• Omar MZ , MetwallyMA, El-FekyHM, AhmedIA, IsmailMA, IdrisA. Role of intrafamilial transmission in high prevalence of hepatitis C virus in Egypt. Hepat. Med., 9, 27–33 (2017).
   PubMed Web of Science ®Google Scholar
• Xu H , YuG, SunHet al. Use of parenteral caffeinum natrio-benzoicum: an underestimated risk factor for HCV transmission in China. BMC Public Health, 15(1), 1–6 (2015).
   PubMedGoogle Scholar
• Ayoub H , AlKanaani Z, Abu-RaddadL. Characterizing the temporal evolution of the hepatitis C virus epidemic in Pakistan. J. Viral Hepat., 25(6), 670–679 (2018).
   PubMed Web of Science ®Google Scholar